A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency Virus
Open Access
- 18 September 1997
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 337 (12) , 801-808
- https://doi.org/10.1056/nejm199709183371201
Abstract
Infection with the human immunodeficiency virus (HIV) greatly increases the risk of reactivation tuberculosis. We evaluated the safety and efficacy of three preventive-therapy regimens in a setting where exposure to tuberculosis is common.Keywords
This publication has 29 references indexed in Scilit:
- Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis. The Makerere University-Case Western Reserve University Research Collaboration.American Journal of Respiratory and Critical Care Medicine, 1996
- Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA)JAMA, 1995
- A prospective study of the risk of tuberculosis among HIV-infected patientsAIDS, 1993
- HIV-associated tuberculosis in developing countries: epidemiology and strategies for preventionTubercle and Lung Disease, 1992
- Cohort Study of Human Immunodeficiency Virus Infection in Patients with Tuberculosis in Nairobi, Kenya: Analysis of Early (6-Month) MortalityAmerican Review of Respiratory Disease, 1992
- High risk of active tuberculosis in HIV-infected drug users with cutaneous anergyPublished by American Medical Association (AMA) ,1992
- Increased Mortality and Tuberculosis Treatment Failure Rate among Human Immunodeficiency Virus (HIV) Seropositive Compared with HIV Seronegative Patients with Pulmonary Tuberculosis Treated with “Standard” Chemotherapy in Kinshasa, ZaireAmerican Review of Respiratory Disease, 1991
- Treatment of Tuberculosis in Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989
- Tuberculosis in Patients with the Acquired Immunodeficiency Syndrome: Clinical Features, Response to Therapy, and SurvivalAmerican Review of Respiratory Disease, 1987